Women with angina pectoris receive less antiplatelet treatment than men

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

In a study investigating the prevalence of underprescription of platelet therapy for women with angina pectoris, the complete medication histories of patients were examined and indicators of possible comorbidity and comedication were recorded. A higher percentage of women than men were not treated with any form of antithrombotic treatment (37% versus 18%), suggesting a serious, and possibly hazardous, undertreatment with acetylsalicylic acid (ASA) in women compared with men.
Original languageEnglish
Pages (from-to)299-300
Number of pages2
JournalBritish Journal of General Practice
Volume49
Issue number441
Publication statusPublished - 9 Mar 1999

Keywords

  • Acetylsalicylic acid
  • Angina pectoris
  • Antiplatelet therapy
  • Ischaemic heart disease
  • acetylsalicylic acid
  • antithrombocytic agent
  • adult
  • aged
  • angina pectoris
  • article
  • comorbidity
  • controlled study
  • female
  • general practice
  • human
  • ischemic heart disease
  • major clinical study
  • male
  • Netherlands
  • oral drug administration
  • prescription
  • sex difference

Fingerprint

Dive into the research topics of 'Women with angina pectoris receive less antiplatelet treatment than men'. Together they form a unique fingerprint.

Cite this